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Abstract 
Dendritic cell (DC) function is modulated by stromal cells including fibroblasts (FB).  Whilst 
poorly understood, the signals delivered through this cross-talk substantially alter DC 
biology.  This is well illustrated with release of TNFα/IL-1β from activated DC, promoting 
PGE2 secretion from stromal FB. This instructs DC to up-regulate IL-23, a key Th17-
polarising cytokine.  We previously showed ionizing radiation (IR) inhibited IL-23 
production by human DC in vitro.  In the present study we investigated the hypothesis that 
DC-FB cross-talk overcomes the suppressive effect of IR to support appropriately 
polarized Th17 responses. 
Radiation (1-6Gy) markedly suppressed IL-23 secretion by activated DC (p<0.0001) 
without adversely impacting their viability, and consequently inhibited the generation of 
Th17 responses. Cytokine suppression by IR was selective as there was no effect on IL-
1β, -6, -10, -27 or TNFα, and only a modest (11%) decrease in IL-12p70 secretion.  Co-
culture with FB augmented IL-23 secretion by irradiated DC and increased Th17 
responses.  Importantly, in contrast to DC, irradiated FB maintained their capacity to 
respond to TNFα/IL-1β and produce PGE2, thus providing the key intermediary signals for 
successful DC-FB crosstalk. 
In summary, stromal FB support Th17 polarizing cytokine production by DC that would 
otherwise be suppressed in an irradiated microenvironment.  This has potential 
ramifications for understanding the immune response to local radiotherapy. These findings 
underscore the need to account for the impact of micro-environmental factors, including 
stromal cells, in understanding the control of immunity. 
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Introduction 
Cross-talk between DC and stromal FB has a marked impact on DC function with regards 
to their ability to mature, migrate, and trigger appropriate adaptive responses [1-3].  Whilst 
the importance of cross-talk between FB and the immune system for the onset and 
maintenance of cancer and autoimmunity was recently recognized, the exact mechanisms 
governing these interactions and the extent to which stromal cells affect the outcome of 
therapeutic interventions like radiotherapy remain poorly understood [4-7].   
Fibroblasts play important roles in the pathology of a wide range of diseases.  Tumor 
associated FB (TAF) promote tolerogenic DC in hepatic, breast and ovarian cancers while 
in pancreatic cancer they skew DC to promote Th2 responses [8-11]. Pulmonary FB are 
involved in the pathology of COPD (chronic obstructive pulmonary disease) and asthma by 
secreting CCL2 (Chemokine (C-C Motif) Ligand 2) and CCL20 (Chemokine (C-C Motif) 
Ligand 20) to attract DC to airways and thus maintain chronic inflammation [12].  Similarly, 
synovial FB are implicated in the perpetuation of rheumatoid arthritis through recruitment 
and activation of leucocytes including T cells, macrophages and DC [7, 13]. Recently we 
established that FB modulate IL-23 secretion by DC to promote Th17 responses and this 
process was implicated in the maintenance and progression of psoriatic lesions [3]. This 
model proposes that dermal FB respond to TNFα (tumor necrosis factor α) and IL-1β, 
secreted from activated DC, by producing PGE2 (prostaglandin E2).  Fibroblast-derived 
PGE2 acts in a juxtacrine manner to amplify IL-23 release from DC thus supporting the 
generation of Th17 responses.  The IL-23/Th17 axis is important for the development and 
maintenance of autoimmune disorders including rheumatoid arthritis, psoriasis and colitis 
[14-17].  IL-23 promotes tumour growth directly and indirectly through Th17 responses that 
drive proliferation, invasion, metastasis and angiogenesis [18-23].  Furthermore, it is 
implicated in the development of idiopathic and radiation-induced fibrosis [24, 25]. 
6 
 
Radiotherapy (RT) is a major tool for the treatment and palliation of tumours including 
squamous cell carcinoma of the skin, breast and primary brain tumours and brain 
metastases [26-28]. Current protocols employ fractionated RT typically comprising 
relatively low doses (1-6Gy) of ionising radiation (IR) administered over a period of weeks 
[26, 29] This allows tumour cells to be targeted with sufficient cumulative dose to deliver 
therapeutic benefit whilst restricting side effects to a tolerable minimum. However, during 
radiotherapy, immune and stromal cells residing in and adjacent to the tumour niche are 
also affected by IR through both direct and bystander effects. Irradiated tumour cells up-
regulate MHC I expression and secrete chemokines and cytokines such as CXCL16 
(Chemokine (C-X-C Motif) Ligand 16), TNFα, IL-1β and IL-6 which in turn stimulate 
infiltration and activation of DC [30]. DC are relatively resistant to radiation-induced 
apoptosis maintaining viability at doses up to 30Gy [31]. Their radio-resistance is a result 
of constitutively expressed DNA repair systems including ATM (ataxia telangiectasia 
mutated) kinase and DNA-PK (DNA-dependent protein kinase) [32]. However, despite this, 
direct exposure of DC to IR suppresses their function. Irradiation of DC down-regulates the 
production of the T cell polarising cytokine IL-12 without affecting IL-10 thus changing the 
ratio between pro and anti-inflammatory stimuli and shifting the balance from T cell 
activation to tolerance [31].  Furthermore, we recently described that IR inhibits secretion 
of IL-23, another T-cell polarising cytokine, by DC [33]. Taken together this suggests that, 
in the setting of local radiotherapy, the cytokine “signal 3” from activated DC is 
substantially modified, thus altering the nature of subsequent T-cell responses.   
We therefore investigated the hypothesis that local FB support IL-23 release by irradiated 
DC and thereby maintain their ability to generate Th17 responses. Doses of radiation 
consistent with those employed for fractionated RT, selectively inhibited IL-23 and to a 
lesser extent IL-12 by DC, without affecting IL-10, IL-6, IL-27, TNFα or IL-1β secretion. 
Interestingly, IR did not affect the capacity of FB to amplify IL-23 secretion by DC. The co-
7 
 
culture of irradiated FB with irradiated DC up-regulated IL-23 secretion and increased 
Th17 responses.  We examined the factors by which FB support the function of DC 
despite the presence of ionizing radiation by employing a DC-FB co-culture system in the 
presence of IR.  The enhancing effect of FB was mimicked by addition of PGE2 or forskolin 
to irradiated DC and was abrogated by treating FB with the COX2 (cyclooxygenase 2) 
inhibitor indomethacin. This effect occurred despite activation of the ATM pathway in 
irradiated DC which we previously established was involved in IL-23 down-regulation [33]. 
These findings indicate that even after exposure to ionizing radiation, activated FB act 
through secretion of PGE2 to activate the cAMP (Cyclic adenosine 3′,5′-monophosphate) 
pathway in irradiated DC, leading to increased IL-23 secretion independent of ATM kinase.  
Our findings not only establish the significance of FB in regulating DC responses but also 
highlight the complex interplay between DC and their microenvironment, and illustrate the 
importance of developing more comprehensive cell biology models for understanding 
immunity. 
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Materials and methods 
Reagents 
All reagents were endotoxin-free. Recombinant human GM-CSF and TNFα were from 
PeproTech, Rocky Hill, NJ; IL-4 and IFNγ were from R&D Systems Europe, Oxford, U.K.; 
Ultrapure TLR4-agonist (Salmonella Minnesota LPS) was from InvivoGen (San Diego, 
CA); Recombinant human IL-1β and IL-6 were from Immunotools, Friesoythe, Germany; 
IL-23 was from eBioscience (San Diego, CA); PGE2, Indomethacin and forskolin were from 
Sigma-Aldrich (Dorset, U.K.). Mouse anti-human CD4-PE was from BD Biosciences 
(Oxford, U.K.); mouse anti-human CD4-PECy7, mouse anti-human CD45RA-FITC, mouse 
anti-human CD14-Pe-Cy5.5 and matching isotype controls were from eBioscience (San 
Diego, CA). For CD4 activation, mouse anti-human CD28 was obtained from BD 
Biosciences, IL-2 (R&D systems), and CD3 (OKT3) was produced in-house. AnnexinV/PI 
staining kit was obtained from BD Bioscience (Oxford, UK). 
 
Generation of monocyte-derived DC  
Monocyte-derived DC were generated as previously described [34]. Briefly, fresh blood 
samples were obtained from healthy volunteers, and buffy coats were obtained from the 
National Blood Transfusion Service in accordance with the approval of the relevant ethical 
review boards. PBMC were isolated using endotoxin-free Histopaque 1.077(Sigma Aldrich, 
Dorset, U.K.) gradient centrifugation. CD14+ monocytes were purified using anti-CD14 
magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). DC were generated by 
culture in DC medium (RPMI 1640, 10% fetal calf serum, 1% sodium pyruvate –all from 
Sigma Aldrich Dorset, U.K- containing recombinant human (rh) GM-CSF (1000 U/mL) and 
rhIL-4 (1000 U/mL) for 5 days.  Additional complete medium was added on day 3. The 
purity and quality of DC were determined by flow-cytometry and morphologic analysis. 
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DC-FB co-culture 
The human dermal FB cell line BJ6 was obtained from Dr. Lloyd Hamilton (University of 
Nottingham) whilst primary dermal FB were obtained from Dr. Anja Saalbach (University of 
Leipzig).  All cells were tested free of mycoplasma infection prior to use.  For co-culture, 
FB were seeded in flat-bottomed 96 well plates and rested overnight. DC were added to 
FB at a 4:1 ratio. Co-cultures were incubated for 24h in a humidified atmosphere of 5% 
CO2 in air at 37oC. Supernatants were collected and stored at -20oC. All experimental 
conditions were performed in biological triplicates and on multiple donors. In some 
experiments the COX-2 inhibitor indomethacin (2µM) was added to FB prior to co-culture 
to determine the contribution of PGE2 synthesis in the induction of IL-23.  For assessment 
of cell-cell interaction Costar Transwell permeable support system was used with FB in the 
lower and DC in the upper chamber separated by 3μm pores.  Primary FB were used up to 
and including the 4th passage after which they were discarded. 
 
Irradiation of cells 
Cells were irradiated in tissue culture plates immediately prior to DC activation with LPS 
(lipopolysaccharide) (500ng/mL) and IFNγ (1000U/mL). For experiments with 
indomethacin, DC were activated 3h before irradiation and adding to FB to minimize the 
effect of COX2 inhibitor on DC maturation.  Cells were irradiated (0-6Gy of 195kVp X-rays, 
0.87Gy/min, 0.5mm Cu filter, 48.4cm FSD) using a Gulmay Xstrahl cabinet irradiation 
system.  Cell morphology was monitored by phase-contrast microscopy (x40) following IR 
and again after a further 24h of culture.  Cell viability, apoptosis and necrosis were 
determined 24h after radiation by trypan blue exclusion and AnnexinV/PI FACS using 
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DMSO as a positive control (not shown).  Flow cytometry was performed using Beckmann 
Coulter FC500 flow cytometer and analyzed with FlowJo software. 
 
Measurement of secreted cytokine 
The secretion of IL-23p40/p19 or IL-12p70 was determined by commercial human IL-23 
Ready-set-go ELISA (eBioscience, San Diego, CA) and human IL-12p70 ELISA kits (BD 
Biosciences, Oxford, U.K.). Assays did not significantly react with other proteins, and the 
sensitivities were 15 and 7.8pg/mL respectively. IL-6 was measured by ELISA 
(ImmunoTools-Friesoythe, Germany) with a sensitivity of 9pg/mL. IL-1β, TNFα, IL-17, IL-
27 and PGE2 were measured with DuoSet assays (R&D Systems Europe, Oxford, U.K), 
and assay sensitivity was 3.9, 15.6, 7.8, 156 and 30.9pg/mL respectively.  Absorbance 
was measured at 450nM using a spectrophotometer.  
 
Generation of Th17 responses 
DC-FB co-cultures were treated as previously described for 12h then washed with fresh 
medium to limit the impact of LPS/IFNγ on T-cells.  We previously established that IL-23 is 
not produced by DC until >12h after TLR (Toll-Like Receptor) stimulation [35]. Human 
naïve CD4+ T cells were obtained from fractionated fresh whole blood and naïve CD4+ 
cells were obtained via a two-step isolation procedure using the Naïve CD4+ T Cell 
Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Isolated T cells 
(CD4+CD45RA+, purity> 95%) were cultured in 48 well plates at 2x105 cells per well.  
Allogeneic T cells were cultured in a 1:1 ratio of fresh medium and DC: FB co-culture 
supernatant for 5 days in the presence of anti-CD3 (OKT3; 1μg/ml) and anti-CD28 
(5μg/ml) antibodies with IL-2 (50IU/ml).  As controls for Th17 polarization and the 
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importance of IL-23, T cells were treated with recombinant IL-1β, IL-6 and IL-23.  T cells 
were rested for 2 days and re-stimulated with anti-CD3/anti-CD28. For flow-cytometric 
assessment of Th17, cells were treated with Brefeldin A (BD Bioscience, Oxford, U.K.) for 
20h, fixed with 0.5% formaldehyde, permeabilized (Perm Buffer, Biolegend, San Diego, 
CA) and incubated with mouse anti-human IL-17 FITC (eBioscience San Diego, CA). Flow 
cytometry was performed using Beckman Coulter FC500 flow cytometer and analyzed with 
FlowJo software. Supernatants from parallel cultures without Brefeldin A were harvested 
after 48h for ELISA. 
 
Measurement of intracellular phospho-ATM 
For measurement of intra-cellular phospho-ATM (pATM) co-cultures were separated using 
0.3μm membrane Transwell plates (Corning, NY, USA). FB were seeded in the lower 
chamber and allowed to rest overnight before DC were added to the upper chambers. 
Cultures were irradiated and immediately activated with LPS/IFNγ.  After 12h, DC were 
fixed in cold 2% formaldehyde/PBS and permeabilized with cold methanol.  Binding of 
primary pATM (Ser1981) (eBioscience San Diego, CA) antibody was detected with a 
FITC-conjugated secondary Ab (Dako, Glostrup, Denmark).  Cells were acquired using a 
MACSQuant cytometer and analyzed using FlowJo. 
 
Quantitation of mRNA level for IL23A, IL12B with real-time RT-PCR 
Real-time PCR was performed as previously described [33, 34]. In short cells were plated 
in DC medium, rested for 1h, irradiated and immediately stimulated with LPS/IFNγ. RNA 
was isolated (Nucleospin RNAII kit, Macherey-Nagel Düren, Germany) and cDNA 
prepared using GoScript Reverse Transcription system, Promega Madison, WI. Taqman 
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quantitative PCR was carried out for IL12B and IL23A with TOP1 as housekeeping gene 
(Applied Biosystems Paisley, UK, TOP1 Hs00243257_m1, Hs00168405_m1, IL-12B/IL-
12p40 Hs00233688_m1, IL-23A/IL-23p19 Hs00372324_m1), with Mastermix (Primer 
Design Southampton, UK) on a Stratagene MX3005P and analyzed with Stratagene 
software. Quantification was done by δδCT method where δCT = (gene of interest 
CT) − (TOP1 CT), δδCT calculated with mDC at 0Gy as reference condition. 
 
Statistical analysis 
Results were statistically analyzed using student’s t-test or 2-way ANOVA in GraphPad® 
Prism software and figures annotated as follows:  *:0.05>p≥0.01, **:0.01p≥0.001, 
***:0.001>p≥0.0001, ****:p<0.0001.  Results are presented as mean ± standard deviation 
(SD). 
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Results 
Irradiated FB recover IL-23 secretion from irradiated DC 
The impact of stromal cells on the response of DC to ionizing radiation has not previously 
been studied. Therefore, we tested the hypothesis that DC-FB cross-talk overcomes the 
immune-inhibitory effect of IR. We recently established that exposure of DC to IR inhibits 
TLR4-dependent IL-23 secretion through the activation of ATM kinase [33].  In agreement 
with this, irradiation of DC significantly suppressed TLR-dependent IL-23 secretion.  
Radiation induced suppression of IL-23 was dose-dependent and maximal at 6Gy 
(p<0.001 Figure 1A) and occurred in all donors tested (p<0.05) (Figure 1B & C, Table 1).  
Co-culture of FB with TLR4-activated DC (mDC) markedly increased the secretion of IL-23 
(p<0.05, Figure 1D).  Furthermore, we determined the ability of irradiated FB to sustain IL-
23 responses from irradiated DC.  Importantly, irradiated FB maintained their ability to 
support increased IL-23 secretion from irradiated DC (p<0.01) in all donors (Figure 1D).  
The levels of IL-23 secreted by irradiated mDC co-cultured with irradiated FB were greater 
than or equal to those obtained from non-irradiated mDC controls.  It should be noted that 
whilst IL-23 secretion was increased in the presence of FB, the levels were nevertheless 
lower than those obtained from non-irradiated co-cultures.  However, the fold increase of 
IL-23 secretion by co-cultures was similar regardless of irradiation (Figure 1E).  The ability 
of FB to increase IL-23 secretion by irradiated DC was maintained regardless of whether 
the BJ6 cell line or primary dermal FB were used (Figure 1F).  As expected, neither 
immature DC (iDC) nor FB secreted IL-23 irrespective of irradiation status or addition of 
FB (data not shown). 
In the presence of IL-6 and IL-1β, IL-23 serves a key role in the polarization of human 
naïve CD4+ T cells towards a Th17 phenotype [33, 36].  Therefore, we determined whether 
the protective effect conferred by FB on IL-23 production resulted in the induction of Th17 
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responses.  Stimulation of naïve CD4+ T cells through CD3/CD28 in the presence of 
conditioned supernatants from mDC cultures elicited Th17 responses as shown by 
secretion of IL-17A (Figure 1G).  Furthermore, the addition of FB to DC enhanced IL-17 
secretion by T cells in all donors tested irrespective of exposure to IR.   
 
Irradiated DC maintain their ability to stimulate fibroblasts 
To determine the mechanism by which FB increase IL-23 secretion in irradiated DC we 
tested each step in the DC-FB co-culture.  Initially we determined if the secretion of TNFα 
and IL-1β were reduced by IR [2]. In contrast to IL-23, DC maintained their secretion of 
TNFα and IL-1β following exposure to IR (Table 1). 
In view of the differential effect of IR on cytokine expression we assessed the secretion of 
other cytokines including IL-12, IL-27, IL-6 and IL-10 (Table 1).  The inhibitory effect of IR 
was restricted to IL-12 and IL-23 which share common p40 subunit. IR strongly down-
regulated IL-23 and only suppressed IL-12 to a modest extent.  Interestingly another 
member of IL-12 family, IL-27, was unaffected. Production of the pro-inflammatory 
cytokine IL-6, as well as anti-inflammatory IL-10 were unaffected by IR.  Next we 
determined whether IR affected transcription of the IL-23-specific IL-23A gene or the 
common IL-12B gene that encodes the p40 chain.  Irradiation of DC (6Gy) significantly 
suppressed transcription of IL-23A when compared with un-irradiated DC (p<0.0001).  
Although the effect of IR on IL-12B was also inhibitory it was nevertheless less marked 
than on IL-23A (Figure 2A, B). 
In contrast to many other cell types (e.g. monocytes), DC remain viable when irradiated 
[37].  This is because DC (but not classical monocytes) have constitutively active DNA-
repair systems that repair double-strand DNA-breaks [38].  We therefore confirmed that 
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the suppression of IL-23 we observed in irradiated DC was not due to apoptosis or 
necrosis. Ionizing radiation did not impact on the viability of DC.  Staining with AnnexinV/PI 
showed the viability of DC to be to be unaffected by IR (Figure 2C). 
 
FB are functionally unimpaired by IR 
Since irradiated DC retained their ability to secrete TNFα/IL1β we next investigated the 
effect of IR on the response of FB to these cytokines.  Co-culture of irradiated FB with non-
irradiated DC did not impair their capacity to promote IL-23 release from mDC (Figure 3A, 
B).  Furthermore, irradiated FB retained their ability to respond to signals received from DC 
and secrete PGE2 since stimulation of irradiated BJ6 and primary FB with exogenous 
TNFα/IL-1β elicited PGE2 secretion which was unaffected by radiation (Figure 3C, D).  As 
expected, exposure of resting FB to radiation did not elicit cytokine release.  In the 
absence of DC, FB did not secrete IL-6, IL-12, IL-10, IL-17, IL-23 or IL-27 in response to 
activation with TNFα, IL-1β or LPS/IFNγ irrespective of exposure to IR (data not shown).  
Irradiation had no impact on FB viability as assessed by dye-exclusion (data not shown) 
and AnnexinV/PI staining (Figure 3E).  It is important to stress that we examined the 
effects of IR on FB within the first 24h of exposure after which time activated DC would be 
expected to migrate to regional LN [39]. 
 
FB support function of irradiated DC through COX2-dependent PGE2 release 
Previously we established the importance of FB for IL-23 secretion by DC and 
demonstrated that this was mediated through COX2-dependent PGE2 [3].  To assess 
whether this mechanism was involved in irradiated cells we first demonstrated the 
involvement of FB-derived soluble factors.  FB were separated from DC by a 0.3µm 
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porous membranes in Transwell plates.  Despite the lack of cell-cell contact, FB retained 
their capacity to support IL-23 secretion from irradiated DC (Figure 4A).  Therefore, we 
evaluated the involvement of PGE2 in up-regulation of IL-23 secretion by irradiated DC.  
The addition of PGE2 to DC immediately after irradiation and activation resulted in a 
significant increase of IL-23 secretion in all donors tested (Figure 4B).  Because PGE2 
secretion by FB is usually COX2 dependent [2, 37] we determined the importance of 
COX2 activation for FB-dependent recovery of IL-23 secretion using the COX2 inhibitor, 
indomethacin.  IL-23 production from irradiated co-cultures was significantly reduced by 
indomethacin (Figure 4C).  In the presence of indomethacin, IL-23 secretion from DC-FB 
co-cultures was reduced to levels similar to those achieved in the absence of FB. 
 
FB promote irradiated DC IL-23 responses through the cAMP pathway 
Irradiation of human DC mono-cultures selectively inhibits IL-23 by phosphorylation of the 
ATM kinase [33].  However PGE2 also up-regulates IL-23 through activation of the cAMP-
PKA (Protein Kinase-A) signaling pathway [40, 41].  Interestingly, in lung cancer cAMP 
signaling inhibits IR-induced phosphorylation of ATM [42].  Therefore, we sought to dissect 
the molecular mechanism responsible for IL-23 secretion in irradiated DC-FB co-cultures.   
We initially assessed ATM activation [3] in irradiated DC mono-cultures or DC-FB co-
cultures.  DC-FB co-cultures were separated by 0.3µm porous membrane to ensure that 
phospho-ATM (pATM) levels were measured only in DC.  As expected, irradiation of mDC 
resulted in ATM phosphorylation after 2h and this persisted for at least 12h as 
demonstrated by intracellular staining with flow cytometry (Figure 4D).  However co-culture 
with FB did not suppress the levels of ATM expressed by irradiated DC suggesting that the 
support of DC function by FB occurred independently of ATM kinase.   Lastly, we 
examined the involvement of the cAMP pathway in regulation of IL-23 from irradiated DC.  
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The addition of the cAMP active analogue Forskolin to irradiated mono-cultures of mDC 
resulted in a dose-dependent increase in IL-23 (p<0.01) (Figure 4E), implicating a role for 
the cAMP signal transduction pathway. 
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Discussion 
Studies on the impact of the stromal microenvironment on immunity are important as 
immune cells are in constant cross-talk with their stroma during each and every stage of 
the immune response.  Stromal cells have the ability to affect a wide range of immune 
functions including DC maturation, their migration to lymph nodes, and subsequent 
polarization of T cell responses [1, 2, 12, 43].  The present study investigated the ability of 
stroma to modulate the outcome of therapeutic interventions directed towards immune 
system. Our previous work established that IR inhibits the cytokine response of DC and in 
particular IL-23 [33]. On the other hand, stromal FB support IL-23 production by activated 
DC [2]. Therefore, we addressed the hypothesis that FB, cells which are known to be 
relatively radio-resistant [44], continue to support the function of DC in the presence of IR. 
The doses of IR used in the current study are similar to those employed during routine 
radiotherapy of common malignancies [26, 29]. At these doses IR damages transformed 
cells and initiates their demise by generating free radicals which induce stress responses 
and consequently cell death if the damage is not repaired [29, 38, 45, 46]. Due to their 
high proliferative rates and impaired DNA repair mechanisms many tumor types are 
selectively sensitive to radiation-induced DNA damage [30, 47]. However, whilst tumor 
cells are the main target for radiotherapy, immune and stromal cells residing in the tumor 
microenvironment are also exposed to and affected by IR [48].  In this regard, previous 
work using mono-cultures has shown that IR suppresses IL-12 secretion by moDC 
between 2 and 20Gy [31] while another report showed increased IL-12 secretion by 
murine DC at 0.05Gy and this effect was reversed to the level of non-irradiated DC at 1Gy 
[49]. The disparity between these findings may be caused by differences in the behavior of 
human and murine DC  however they may also reflect different mechanisms of action for 
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IR at extremely low doses (0.05-1Gy) comparing to higher doses used for radiotherapy (2-
6Gy)[26, 50].     
We found that the inhibitory effect of IR was restricted to IL-12 family members sharing the 
common p40 subunit.  However, the effect was considerably more pronounced for IL-23 
than IL-12p70. Interestingly the maximal effect of IR was exerted at 6Gy with a plateau of 
effect at higher doses. This may be due to ATM reaching its maximum activation state at 
this dose. On the other hand, the effect of IR did not extend to the other IL-12 family 
member, IL-27. IL-27 comprises the IL-27p28 subunit and Epstein–Barr virus-induced 
gene 3 (EBI3) which are related to p35 and p40 respectively [51]. Those findings 
demonstrate the highly selective effect of IR on DC functions with prevalence to inhibit 
Th17 responses. The lack of effect of IR on TNFα and IL-1β had important consequences 
for our multicellular model as it allowed activated DC to sustain their interactions with FB 
and generate the PGE2 feedback loop [3]. Irradiated FB also continued to support the 
production of IL-23 by DC irrespective of the dose of IR to which FB were exposed. This 
was observed not only with a FB cell line, but also with primary dermal FB thus supporting 
the potential physiological importance of this observation. 
Fibroblasts (resting, TLR-activated, or irradiated) were not responsible for the secretion of 
any of the cytokines affected by IR. Previous reports describe FB expression of the 
IL23p19 subunit upon stimulation with IL-1β [52] but to the best of our knowledge there are 
no reports of IL-23 heterodimer secretion [53]. It is important to recognize the difference 
between biologically active IL-23 heterodimer secreted by APC, and IL-23p19 monomer 
and in the current study we measured heterodimeric IL-23 secretion [53].  
It is known that FB can enter a senescent phase when exposed to IR yet remain viable 
[18, 44, 54].  This represents one of the important mechanisms of tumor development as in 
this state senescent FB alter their phenotype and promote tumor growth, invasion and 
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render adjacent tumor cells increasingly radio-resistant [44]. Therefore, we assessed the 
effect of IR on FB in functional assays. PGE2 stimulates IL-23 secretion in human and 
murine DC [2, 41, 55, 56]. Previous reports have published conflicting data in regard to 
regulation of PGE2 secretion by gingival FB irradiated with low-level diode laser [57, 58].  
In our model, irradiation of dermal FB did not alter PGE2 secretion in response to 
exogenous TNFα and IL-1β, and this likely accounts for their continued capacity to 
augment IL-23 release by non-irradiated DC.  Therefore, irradiated FB were unimpaired in 
their ability to secrete soluble immune modulators and maintained their capacity to 
respond to environmental stimuli. 
According to recent reports PGE2 stimulates IL-23 secretion from DC through activation of 
the cAMP/PKA pathway [40, 41]  and we previously described that IR down-regulates IL-
23 through phosphorylation of ATM kinase [33].  Interestingly, cAMP signaling inhibits 
radiation induced phosphorylation of ATM in lung cancer [42].  Addition of forskolin 
increased IL-23 secretion by irradiated DC to levels commensurate with those from 
irradiated DC-FB co-cultures, suggesting a role for cAMP.  However, in contrast to Cho 
and colleagues, co-culture of irradiated DC with FB did not affect pATM levels despite up-
regulated IL-23. This disparity may be due to differences in timing of cAMP and ATM 
activation.  Cho and co-workers activated cAMP before irradiation of cells thus preventing 
phosphorylation of ATM by activated PP2A (Protein phosphatase 2A).  In our study DC 
were irradiated before activation and subsequent stimulation from FB. Since ATM is 
phosphorylated in DC within 15min of IR [33], signals from FB are received by DC too late 
to inhibit ATM activation.  It is therefore even more notable that up-regulation of IL-23 
secretion by FB occurred despite ATM activation. 
The impact of FB on the ability of irradiated DC to promote Th17 responses was 
examined.  Previously we and others established the role of IL-23 in the generation of 
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Th17 [2, 33, 56]. In agreement with this, IL-17 secretion from T-cells conditioned with 
supernatants from DC-FB co-cultures was enhanced as compared to supernatants from 
DC mono-culture. PGE2 was shown to promote Th17 directly and in conjunction with IL-23 
[59, 60]. In our model the concentration of PGE2 secreted by FB was unaffected by IR.  On 
the other hand, changes in IL-17 reflected differences in IL-23 levels, demonstrating the 
biological importance of FB-dependent IL-23 secretion in regulation of adaptive immunity.  
In summary we show that although IR inhibits IL-23 secretion from DC mono-cultures, the 
inclusion of FB provides a positive feedback loop that serves to maintain IL-23 secretion 
by DC.   We propose that this translates to enhanced Th17 responses in a post-RT 
environment (Fig 5) and studies to investigate this are underway.  Since IL-17 is a critical 
factor driving post-radiation fibrosis [24] this work identifies a potential mechanism for the 
pathological consequences of radiation and chemotherapy [25, 61].  Importantly it 
highlights the need for multicellular models of the immune microenvironment.  Insight into 
the complex interactions between the immune system and stroma is necessary to our 
understanding of pathology and for development of novel therapeutic interventions. 
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Figure legends 
Figure 1. FB promote IL23-Th17 axis during irradiation. IR suppresses IL-23.  DC were 
irradiated prior to addition of LPS/IFNγ and IL-23 release measured by ELISA; A – IL-23 
suppression was dependent on the dose of IR (a representative donor from 3).  B- shows 
a representative experiment at 6Gy and C - shows a summary of 18 donors.  D - FB 
rescue IL-23 secretion by irradiated DC. Co-culture of irradiated FB with irradiated DC up-
regulated IL-23 secretion (summary of 8 donors).  E -  shows fold change of IL-23 
secretion by irradiated DC/FB co-cultures at 0 and 6Gy. F - Primary dermal FB 
demonstrate similar IL-23-enhancing activity to the BJ6 cell line (data from a 
representative donor or 5).  G -  FB permit irradiated DC to promote Th17 responses. IL-
17A secretion by naïve CD4+ T cells activated with anti-CD3/anti-CD28 in the presence of 
supernatants of the indicated DC/FB cultures. T-cells were stimulated for 5 days and IL-
17A secretion determined after re-stimulation (collective data from 3 donors). Error bars 
indicate standard deviation (SD) of triplicate experiments.  
 
Table 1. Effect of IR on cytokine secretion by mDC. DC were irradiated (6Gy) or non-
irradiated before activation with LPS/IFNγ.  Supernatants were collected following 24h 
incubation and secreted IL-23, IL-12, IL-27, IL-1β, TNFα, IL-6 and IL-10 were measured by 
ELISA.  All experiments were repeated at least 4 times in triplicate and significance was 
assessed with 2-way ANOVA. 
 
Figure 2. Effect of IR on DC. Changes in IL-23 secretion were associated with decreased 
transcription of the; A - IL-23A gene and B - IL-12B gene as shown using Q-RT-PCR in 3 
donors. Statistical significance was measured by the student t-test. C – Despite exposure 
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to up to 6Gy IR, there was no decrease in viability of DC as assayed by AnnexinV /PI 
staining with flow-cytometry up to 72h after irradiation. Representative result for 1 of 3 
donors tested.  
 
Figure 3. FB are functionally resistant to IR. Irradiation of FB did not impair their ability 
to up-regulate IL-23 secretion from non-irradiated DC; A - shows a representative donor, B 
- summary of 3 donors.  C - PGE2 secretion (determined by ELISA) by FB stimulated with 
recombinant TNFα and IL1β (1ng/mL) is unaffected by IR; C - BJ6 cell line and D- 
representative results for 1 of 2 primary FB donors.  E - IR (6Gy) does not affect FB 
viability up to 24h after irradiation as assessed by AnnexinV/PI staining; representative 
data from 3 experiments. 
 
Figure 4. Mechanisms of IL-23 recovery from irradiated DC by FB. FB-dependent IL-
23 secretion from irradiated DC is mediated by soluble factors and was independent of 
cell-cell contact. A - Shows fold increase in IL-23 secretion by DC separated from FB with 
Transwell (0.3μm) treated with IR (summary of 3 donors).  B - Addition of PGE2 to 
irradiated DC up-regulates IL-23 secretion (summary of 5 donors). C - Up-regulation of IL-
23 secretion from irradiated DC by FB is COX2 dependent. FB were treated with 
Indomethacin for 24h prior to (and throughout) co-culture with irradiated DC (data from 3 
experiments).  D - FB did not affect ATM phosphorylation in irradiated DC.  Irradiated mDC 
cultured with FB (blue line) or without FB (orange line) show similar levels of ATM 
phosphorylation.  In both these settings, IR increased ATM activation when compared with 
non-irradiated mDC (red line) as demonstrated by intracellular staining for flow-cytometry 
at 2 and 12 h after IR (6Gy, representative donor of 3).  E - Stimulation of TLR4-activated 
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DC with the c-AMP agonist forskolin immediately following exposure to IR increased IL-23 
secretion (data from 3 representative donors.) 
 
Figure 5. Model of DC-FB crosstalk governing IL-23 dependent Th17 responses after 
irradiation.  
A:  TLR-activation of DC in mono-culture elicits secretion of IL-1β, -6 and -23 which prime 
Th17 responses.  B:  The addition of FB to DC provides an important feedback loop that 
serves to enhance IL-23 secretion and thus augments Th17 responses.  C:  Irradiation of 
DC mono-cultures selectively inhibits IL-23 secretion.  D:  However, the presence of FB 
ensures that irradiated DC continue to secrete sufficient IL-23 to generate Th17 
responses.  Importantly, the irradiation of FB does not hinder their reinforcement of IL-23 
responses. 





 Table 1. 
 
Cytokine % remaining 
secretion 
SD P value
IL-23 43 11 <0.0001
IL-12 89 16.3 0.0005 
IL-27 100.9 36.6 ns 
IL-1β 93.5 34.4 ns 
TNFα 111.8 29.6 ns 
IL-6 174.1 114.4 ns 
IL-10 95.9 6.2 ns 
 
 
 
 
